MoonLake Immunotherapeutics (MLTX)
45.26
+2.69
(+6.32%)
USD |
NASDAQ |
May 03, 16:00
45.23
-0.03
(-0.07%)
After-Hours: 20:00
MoonLake Immunotherapeutics Market Cap: 2.846B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.846B |
| May 02, 2024 | 2.677B |
| May 01, 2024 | 2.694B |
| April 30, 2024 | 2.572B |
| April 29, 2024 | 2.626B |
| April 26, 2024 | 2.672B |
| April 25, 2024 | 2.656B |
| April 24, 2024 | 2.668B |
| April 23, 2024 | 2.719B |
| April 22, 2024 | 2.579B |
| April 19, 2024 | 2.653B |
| April 18, 2024 | 2.656B |
| April 17, 2024 | 2.736B |
| April 16, 2024 | 2.735B |
| April 15, 2024 | 2.744B |
| April 12, 2024 | 2.761B |
| April 11, 2024 | 2.870B |
| April 10, 2024 | 2.904B |
| April 09, 2024 | 2.939B |
| April 08, 2024 | 2.909B |
| April 05, 2024 | 2.966B |
| April 04, 2024 | 2.892B |
| April 03, 2024 | 2.890B |
| April 02, 2024 | 2.971B |
| April 01, 2024 | 3.056B |
| Date | Value |
|---|---|
| March 28, 2024 | 3.158B |
| March 27, 2024 | 3.157B |
| March 26, 2024 | 3.149B |
| March 25, 2024 | 3.253B |
| March 22, 2024 | 3.269B |
| March 21, 2024 | 3.293B |
| March 20, 2024 | 3.112B |
| March 19, 2024 | 3.181B |
| March 18, 2024 | 3.053B |
| March 15, 2024 | 2.971B |
| March 14, 2024 | 2.753B |
| March 13, 2024 | 2.823B |
| March 12, 2024 | 2.895B |
| March 11, 2024 | 2.958B |
| March 08, 2024 | 2.868B |
| March 07, 2024 | 2.866B |
| March 06, 2024 | 2.843B |
| March 05, 2024 | 3.024B |
| March 04, 2024 | 3.072B |
| March 01, 2024 | 3.202B |
| February 29, 2024 | 3.033B |
| February 28, 2024 | 3.435B |
| February 27, 2024 | 3.311B |
| February 26, 2024 | 3.152B |
| February 23, 2024 | 3.147B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
173.18M
Minimum
May 16 2022
3.861B
Maximum
Feb 12 2024
1.550B
Average
926.72M
Median
Market Cap Benchmarks
| Qiagen NV | 9.535B |
| LENZ Therapeutics Inc | 420.28M |
| AC Immune SA | 236.37M |
| CRISPR Therapeutics AG | 4.744B |
| Addex Therapeutics Ltd | 9.566M |
Market Cap Related Metrics
| Price to Book Value | 5.741 |
| Price | 45.26 |
| Earnings Yield | -1.64% |